4//SEC Filing
Prelude Ventures LLC 4
Accession 0001104659-23-084296
CIK 0001822691other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 4:11 PM ET
Size
8.1 KB
Accession
0001104659-23-084296
Insider Transaction Report
Form 4
Prelude Ventures LLC
Other
Transactions
- Other
Common Stock
2023-07-24−3,189,151→ 0 total(indirect: See Footnote)
Prelude Fund, LP
Other
Transactions
- Other
Common Stock
2023-07-24−3,189,151→ 0 total(indirect: See Footnote)
Footnotes (2)
- [F1]This Form 4 reports securities contributed by the Reporting Person in connection with the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2023, by and among GreenLight Biosciences Holdings, PBC, SW ParentCo, Inc. ("Parent"), and SW MergerCo, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), to Merger Sub in exchange for shares of Series A-2 Preferred Stock, par value $0.001 per share, of Parent pursuant to a Contribution and Exchange Agreement, dated May 29, 2016 (the "Contribution and Exchange Agreement"), between Parent and Prelude Ventures LLC. The price used to calculate the value of each share of Series A-2 Preferred Stock for purposes of the exchange was $0.40 per share, as determined pursuant to the terms of the Contribution and Exchange Agreement.
- [F2]Prelude Ventures LLC is the general partner of Prelude Fund, LP, the record holder of the securities. Prelude Ventures LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Documents
Issuer
GreenLight Biosciences Holdings, PBC
CIK 0001822691
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001980229
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 4:11 PM ET
- Size
- 8.1 KB